| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -17.27M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMRX returned +8.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -19.5% |
| 1 year | +8.4% |
| 5 years | -78.3% |
| All-time high | $27.10 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IMRX would be worth today ›No. Immuneering Corporation has not paid a dividend in the past 12 months.
Immuneering Corporation stock trades on NASDAQ under the ticker symbol IMRX.
Immuneering Corporation is part of the Healthcare sector.
Immuneering Corporation has a market cap of 342.90M USD, based on the latest quote.
